These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 32084217)
1. The role of Glial cell derived neurotrophic factor in head and neck cancer. Cao H; He Q; Eyben RV; Bloomstein J; Nambiar DK; Viswanathan V; Aggarwal S; Kwok S; Liang R; Koong AJ; Lewis JS; Kong C; Xiao N; Le QT PLoS One; 2020; 15(2):e0229311. PubMed ID: 32084217 [TBL] [Abstract][Full Text] [Related]
2. Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation. Liu C; Sadat SH; Ebisumoto K; Sakai A; Panuganti BA; Ren S; Goto Y; Haft S; Fukusumi T; Ando M; Saito Y; Guo T; Tamayo P; Yeerna H; Kim W; Hubbard J; Sharabi AB; Gutkind JS; Califano JA Clin Cancer Res; 2020 Jun; 26(11):2693-2703. PubMed ID: 31932491 [TBL] [Abstract][Full Text] [Related]
3. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma. Berggren KL; Restrepo Cruz S; Hixon MD; Cowan AT; Keysar SB; Craig S; James J; Barry M; Ozbun MA; Jimeno A; McCance DJ; Beswick EJ; Gan GN Oncogene; 2019 Nov; 38(48):7329-7341. PubMed ID: 31417185 [TBL] [Abstract][Full Text] [Related]
4. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma. Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310 [TBL] [Abstract][Full Text] [Related]
5. Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma. An JS; Moon JH; Kim C; No JK; Eun YG; Chang Lim Y Exp Cell Res; 2021 Oct; 407(2):112815. PubMed ID: 34496296 [TBL] [Abstract][Full Text] [Related]
6. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients. Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364 [TBL] [Abstract][Full Text] [Related]
7. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status. Du S; Liu K; Gao P; Li Z; Zheng J Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648 [TBL] [Abstract][Full Text] [Related]
8. Radiosensitization approaches for HPV-positive and HPV-negative head and neck squamous carcinomas. Dok R; Bamps M; Glorieux M; Zhao P; Sablina A; Nuyts S Int J Cancer; 2020 Feb; 146(4):1075-1085. PubMed ID: 31283004 [TBL] [Abstract][Full Text] [Related]
10. Clinical implications of activation of the LIMD1-VHL-HIF1α pathway during head-&-neck squamous cell carcinoma development. Mukhopadhyay D; Chakraborty B; Sarkar S; Alam N; Panda CK Indian J Med Res; 2024 May; 159(5):479-493. PubMed ID: 39382421 [TBL] [Abstract][Full Text] [Related]
11. TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients. Sacconi A; Donzelli S; Pulito C; Ferrero S; Spinella F; Morrone A; Rigoni M; Pimpinelli F; Ensoli F; Sanguineti G; Pellini R; Agrawal N; Izumchenko E; Ciliberto G; Giannì A; Muti P; Strano S; Blandino G J Exp Clin Cancer Res; 2020 Sep; 39(1):200. PubMed ID: 32967703 [TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinoma. Broutian TR; Jiang B; Li J; Akagi K; Gui S; Zhou Z; Xiao W; Symer DE; Gillison ML Cancer Lett; 2020 Apr; 476():23-33. PubMed ID: 31958486 [TBL] [Abstract][Full Text] [Related]
13. Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins. Tanaka N; Patel AA; Wang J; Frederick MJ; Kalu NN; Zhao M; Fitzgerald AL; Xie TX; Silver NL; Caulin C; Zhou G; Skinner HD; Johnson FM; Myers JN; Osman AA Clin Cancer Res; 2015 Nov; 21(21):4831-44. PubMed ID: 26124202 [TBL] [Abstract][Full Text] [Related]
14. Subjugation of TGFβ Signaling by Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma Shifts DNA Repair from Homologous Recombination to Alternative End Joining. Liu Q; Ma L; Jones T; Palomero L; Pujana MA; Martinez-Ruiz H; Ha PK; Murnane J; Cuartas I; Seoane J; Baumann M; Linge A; Barcellos-Hoff MH Clin Cancer Res; 2018 Dec; 24(23):6001-6014. PubMed ID: 30087144 [TBL] [Abstract][Full Text] [Related]
15. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma. Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164 [TBL] [Abstract][Full Text] [Related]
16. Association of lnc-IL17RA-11 with increased radiation sensitivity and improved prognosis of HPV-positive HNSCC. Song L; Xie H; Tong F; Yan B; Zhang S; Fu E; Jing Q; Wei L J Cell Biochem; 2019 Oct; 120(10):17438-17448. PubMed ID: 31119798 [TBL] [Abstract][Full Text] [Related]
17. Brain-Derived Neurotrophin and TrkB in Head and Neck Squamous Cell Carcinoma. Dudás J; Riml A; Tuertscher R; Pritz C; Steinbichler TB; Schartinger VH; Sprung S; Glueckert R; Schrott-Fischer A; Johnson Chacko L; Riechelmann H Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641914 [TBL] [Abstract][Full Text] [Related]
18. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272 [TBL] [Abstract][Full Text] [Related]
19. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients. Li J; Tang LL; Ma J BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785 [TBL] [Abstract][Full Text] [Related]
20. Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients. Laban S; Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende CC; Dyckhoff G; Boscolo-Rizzo P; Ezić J; Marienfeld R; Möller P; Kraus JM; Völkel G; Kestler HA; Brunner C; Schuler PJ; Wigand MC; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Waterboer T; Butt J Clin Cancer Res; 2019 Dec; 25(24):7405-7412. PubMed ID: 31444248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]